Fund of Funds

Teralys Capital

Investment Details

Investor Type
Fund of Funds

Asset Class Focus
Venture Capital

Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed

Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, China, France, Denmark, Switzerland, Luxembourg, South Korea, Netherlands, New Zealand, Sweden, Belgium, Norway, Finland

Industries Focus

  • Life Sciences
  • Information Technology
  • Clean Technology
  • Industrial Innovations

Investment Size:
1,000,000 to 50,000,000 USD

Investor Details Founded: 2009

Teralys Capital is a private fund manager specializing in financing private venture capital funds that invest in information technology, life sciences, and clean or industrial innovations. With over $2.5 billion in assets under management across five specialized venture capital fund-of-funds, Teralys is the largest innovation-focused investor in Canada. The firm has been supported since its inception in 2009 by a growing local and international limited partner base. Teralys also invests internationally to benefit from favorable returns in established markets abroad and to support Canadian technology funds and entrepreneurs by extending their international reach and bringing back best practices from around the globe.

The firm's partner funds cover the entire investment spectrum, from early-stage start-ups to expansion, growth, and technology buy-outs. Teralys Capital's mission is to propel outstanding technology entrepreneurs to successfully innovate, grow, and bring game-changing ideas to the world marketplace. The firm aims to foster the development of a renewed and efficient venture capital sector, leading to stronger returns for all players and more globally competitive Canadian technology companies.

Teralys Capital has a strong track record of supporting technology funds and companies across key innovation sectors, including information technology, life sciences, and clean and industrial innovations. The firm's founding principle remains to propel entrepreneurs to successfully grow their businesses into anchor companies across fields vital to Canada's new economy, such as artificial intelligence and precision medical therapies, generating benefits to all stakeholders and delivering strong financial performance for its investors.

Requirements
  • Focus on information technology, life sciences, and clean or industrial innovations
  • Investments across all stages from early-stage start-ups to expansion, growth, and technology buy-outs
  • Preference for companies with strong growth potential and innovative solutions
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Zymeworks
  • Lightspeed
  • eSentire
  • Luxury Retreats
  • Turnstone Biologics
  • Verafin
Mentioned In
Claim this Investor

Are you an official representative of Teralys Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim